Announcements Trials
Browse Landscape

Status

Completed 81Unknown 30Recruiting 18Not yet recruiting 9Active not recruiting 8Withdrawn 7Terminated 3Enrolling by invitation 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 14Observational 3

Sponsor

Conditions

Breast Neoplasms 138Neoplasms 134Lung Neoplasms 68Prostatic Neoplasms 67Carcinoma, Non-Small-Cell Lung 58Colorectal Neoplasms 45Multiple Myeloma 37Pancreatic Neoplasms 33Melanoma 32Head and Neck Neoplasms 30Brain Neoplasms 30Neoplasm Metastasis 28Ovarian Neoplasms 27Liver Neoplasms 27Carcinoma, Hepatocellular 27Leukemia, Myeloid, Acute 25Colonic Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma 20Leukemia, Lymphocytic, Chronic, B-Cell 20Esophageal Neoplasms 20Carcinoma, Renal Cell 20Lymphoma, Non-Hodgkin 19Urinary Bladder Neoplasms 18Stomach Neoplasms 18Glioblastoma 18Uterine Cervical Neoplasms 17Sarcoma 17Lymphoma, Follicular 17Lymphoma, Large B-Cell, Diffuse 16

Interventions

Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Observational × Papillomavirus Infections × Clear all
NCT01290393 2018-07-26

Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada

GlaxoSmithKline

Terminated
2 enrolled

Abortion, Spontaneous, Papillomavirus Infections

NCT01355003 2015-08-13

GARDASILâ„¢ Post Marketing Surveillance in the Philippines (V501-077)

Merck Sharp & Dohme LLC

Terminated
1,080 enrolled

Papillomavirus Infections

NCT00924794 2015-04-20

Study of Natural History of Human Papillomavirus (HPV) Infections in Adult Women With Recurrent Conizations in Norway

GlaxoSmithKline

Terminated
410 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡